Unolab
Unolab is a leading Spanish company specializing in the manufacture of monodose sterile products for third parties, with a strong commitment to quality, innovation, and environmental sustainability. Established in 2006, it has grown to become one of Europe's main manufacturers in this sector, offering turnkey services in formula development and production of healthcare products and medications. Unolab operates internationally in over 30 countries, adhering to strict quality standards such as GMP and ISO 13485, and is committed to environmental measures like waste sorting, recycling, and transport optimization. The company emphasizes quality, trust, agility, and flexibility in its operations, and continuously participates in major industry events worldwide to strengthen its market presence.
Industries
Nr. of Employees
medium (51-250)
Products
Sterile 0.9% saline — ophthalmic single-dose formats
Sterile 0.9% sodium chloride solutions for eye, nose and contact lens cleansing supplied in single-dose vials across small-volume formats (e.g., 0.4 mL, 2 mL, 3 mL, 5 mL, 10 mL).
Buffered sterile saline — ophthalmic single-dose
Buffered 0.9% saline for eye and contact lens care offered in single-dose formats (e.g., 5 mL, 10 mL).
Hyaluronic acid lubricating solution — ophthalmic single-dose
Sterile lubricating eye solution containing hyaluronic acid (e.g., 0.10%) supplied in single-dose 0.4 mL formats for eye lubrication and contact lens maintenance.
Sterile saline and hypertonic solutions for nebulization — single-dose
Sterile solutions for nebulisation and inhalation including 0.9% saline and hypertonic formulations (1.5%, 3%, 5%, 7%), with some variants containing hyaluronic acid; supplied in single-dose 2.5 mL and 5 mL formats.
Sterile 0.9% saline — ophthalmic single-dose formats
Sterile 0.9% sodium chloride solutions for eye, nose and contact lens cleansing supplied in single-dose vials across small-volume formats (e.g., 0.4 mL, 2 mL, 3 mL, 5 mL, 10 mL).
Buffered sterile saline — ophthalmic single-dose
Buffered 0.9% saline for eye and contact lens care offered in single-dose formats (e.g., 5 mL, 10 mL).
Hyaluronic acid lubricating solution — ophthalmic single-dose
Sterile lubricating eye solution containing hyaluronic acid (e.g., 0.10%) supplied in single-dose 0.4 mL formats for eye lubrication and contact lens maintenance.
Sterile saline and hypertonic solutions for nebulization — single-dose
Sterile solutions for nebulisation and inhalation including 0.9% saline and hypertonic formulations (1.5%, 3%, 5%, 7%), with some variants containing hyaluronic acid; supplied in single-dose 2.5 mL and 5 mL formats.
Services
End-to-end manufacturing of sterile single-dose products using blow-fill-seal technology, offered as product transfer or full development and production service.
Integrated laboratory services for formulation development for ophthalmic and respiratory single-dose products, and analytical method development and validation to support release and registration.
Process design, scale-up, pilot batches and production of batches intended for clinical trials, including process validation support and clinical-scale manufacturing.
Regulatory strategy, dossier preparation and submission support for medicines and medical devices, including guidance on conformity pathways and quality system compliance.
Execution of stability studies according to ICH climatic zones and specified storage conditions, with protocol drafting and report delivery suitable for regulatory submissions.
End-to-end manufacturing of sterile single-dose products using blow-fill-seal technology, offered as product transfer or full development and production service.
Integrated laboratory services for formulation development for ophthalmic and respiratory single-dose products, and analytical method development and validation to support release and registration.
Process design, scale-up, pilot batches and production of batches intended for clinical trials, including process validation support and clinical-scale manufacturing.
Regulatory strategy, dossier preparation and submission support for medicines and medical devices, including guidance on conformity pathways and quality system compliance.
Execution of stability studies according to ICH climatic zones and specified storage conditions, with protocol drafting and report delivery suitable for regulatory submissions.
Expertise Areas
- Single-dose aseptic manufacturing (BFS)
- Formulation development for ophthalmic and inhalation products
- Analytical method development and validation
- Process development and scale-up for aseptic filling
Key Technologies
- Blow-fill-seal aseptic filling
- Clean-in-place (CIP) and sterilize-in-place (SIP) systems
- ISO Class 5 cleanroom filling environments
- Automated dosing and filling systems
News & Updates
Unolab - CDTi Agreement
Unolab received a CDTi financing grant for new technological equipment in Getafe, supporting its growth as a CDMO in Europe.
Pharmavenue 2022
Major pharmaceutical industry event in Marbella for networking and opportunity generation.
EuroPLX 80
Bilateral meetings in Athens to strengthen and showcase the European market.
Cphl Frankfurt 2022
Participation in a leading global pharmaceutical trade fair with a stand for new business opportunities.
DOG Congress Berlin 2022
Congress of leading companies in the German optical sector.
BFS IOA Lyon 2022
International association for BFS manufacturing companies, with a congress in Lyon.
Unolab - CDTi Agreement
Unolab received a CDTi financing grant for new technological equipment in Getafe, supporting its growth as a CDMO in Europe.
Pharmavenue 2022
Major pharmaceutical industry event in Marbella for networking and opportunity generation.
EuroPLX 80
Bilateral meetings in Athens to strengthen and showcase the European market.
Cphl Frankfurt 2022
Participation in a leading global pharmaceutical trade fair with a stand for new business opportunities.
DOG Congress Berlin 2022
Congress of leading companies in the German optical sector.
BFS IOA Lyon 2022
International association for BFS manufacturing companies, with a congress in Lyon.